Total raised
—
Last: Seed 2013-11
Stage
Seed
Founded
2012
Headcount
6
HQ
Yavne
Sector
Health Tech & Life Sciences
About
ChanBio is a biopharmaceutical company dedicated to the development of functional antibody-based modulators active on ion channels and G-protein-coupled receptors (GPCRs). The company is developing treatments for multiple sclerosis as well as other autoimmune, cardiovascular, cancer-related, and pain disorders. ChanBio operates out of the Merck Serono Israel, the Bioincubator of Merck Inc.
Funding history · 2 rounds · — total
2013-11
Seed
Undisclosed
2013-01
Undisclosed
Undisclosed
Sectors & technology
Primary sector
Health Tech & Life Sciences
Sub-sectors
Health Tech & Life SciencesPharma & Medical BiotechnologyDrugs Discovery & Development
Technologies
Biologicals
Target customers
Healthcare & Life SciencesLife SciencesPharmaceuticals
Business model
B2B
Highlights
1 Patents
Tags
canceroncologybiopharmaceuticalcardiovascularpharmaceuticalsbiotechnologychronic-painantibodiescardiologytreatmentsautoimmune-diseases